Delivery Order SPE2DB20D2104-SPE2DB25FMREG
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,477.57 for Lumigan 0.01% eye drops (7.5mL) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery of pharmaceutical products to support federal medical procurement needs. The work will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $2,210.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5mL) on June 6, 2025, with an ultimate completion date of June 9, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.12 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,768.84 to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops (5ml) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $1,987.06 delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lumigan 0.01% Eye Drops (5mL) with a ceiling value of $1,173.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LUMIGAN 0.01% eye drops. The $4,409.48 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,284.09 for the supply of Lumigan 0.01% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 1, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMREGDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,470.15 on August 6, 2025, for the supply of Lumigan 0.01% eye drops in 5mL quantities. This non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems. The company maintains a significant presence in federal contracting through competitively awarded delivery orders with the Defense Logistics Agency across multiple therapeutic domains. This particular order for ophthalmic medication reflects the company's role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare systems through DLA's global pharmaceutical support programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/6/25 |